Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Nat Prod Commun. 2016 Jun;11(6):719–721.

New Antiplasmodial Diterpenes from Gutierrezia sarothrae

Qingxi Su a, Seema Dalal b, Michael Goetz c, Maria B Cassera b, David G I Kingston a,
PMCID: PMC5352980  NIHMSID: NIHMS849129  PMID: 27534100

Abstract

Bioassay guided fractionation of the MeOH extract of the plant Gutierrezia sarothrae (Asteraceae) using an assay for antiplasmodial activity against the drug-resistant Dd2 strain of Plasmodium falciparum led to the isolation of the two new diterpenes 3α-angeloyloxy-15-hydroxylabda-7,13-dien-16,15-olid-18-oic acid (1) and 3α-angeloyloxy-15-methoxylabda-7,13-dien-16,15-olid-18-oic acid (2). The structures of 1 and 2 were elucidated by interpretation of 1D and 2D NMR spectroscopic data, mass spectrometry, and comparison with the data of related compounds reported in the literature. Compound 1 exhibited moderate antiplasmodial activity with an IC50 values of 10.4 ± 4.3 µM.

Keywords: Antimalarial activity, diterpenes, Gutierrezia sarothrae (Asteraceae)


The family Asteraceae (or Compositae) contains many perennial herbs as well as subshrubs that are important weeds on rangelands [1]. Gutierrezia sarothrae, a member of this family, is widely distributed in the rangelands of western North America [2]. The plant has been used externally to treat bee stings, snake bites, flesh wounds [3], and rheumatism [4]. Previous studies have indicated that the plant contains monoterpenes [5], volatile components such as cryptone and β-eudesmol [2], flavonoids [6], and labdane derivatives [7a,7b]. An antitumor proteinaceous substance has also been reported from the plant [8]. However, G. sarothrae has not previously been studied for potential antimalarial constituents.

In continuation of our investigation of antimalarial agents from plants [9a,9b], we obtained a sample of the methanolic extract of G. sarothrae. The crude extract was selected for investigation based on its antiplasmodial activity (IC50 between 5 and 10 µg/mL) against the Dd2 strain of the P. falciparum parasite. Bioassay-guided fractionation afforded the two new labdane derivatives 3α-angeloyloxy-15-hydroxylabda-7,13-dien-16,15-olid-18-oic acid (1) and 3α-angeloyloxy-15-methoxylabda-7,13-dien-16,15-olid-18-oic acid (2). We report herein the bioassay-guided isolation and structure elucidation of the two new compounds, as well as their antimalarial activity.

Liquid-liquid partition of the crude MeOH extract of G. sarothrae (800 mg) yielded antiplasmodial hexane and dichloromethane soluble fractions (IC50 ca. 5 µg/mL each). These fractions were combined and subjected to size-exclusion column chromatography on Sephadex LH-20 followed by normal phase diol open column chromatography. The most active fraction from the diol column was subjected to semi-preparative C18 HPLC to yield the two new labdane diterpenes (12).

Compound 1 was obtained as a colorless oil and had the molecular formula C25H34O7 as indicated by HRESIMS analysis (m/z 469.2218 [M+Na]+, calcd. for C25H34O7Na+, 469.2197; 915.4543 [2M+Na]+, calcd. for C50H68O14Na+, 915.4501). Its 1H NMR spectrum (Table 1) indicated the presence of five methyl groups, including three singlets (δH 0.82, 1.30 and 1.72, each 3H) and two multiplets (δH 1.93, dq, J = 7.0, 1.5 Hz, 3H and 1.83, m, 3H); five downfield protons between δ 5.23 and 6.88; and a number of multiplets between δ 1.30 and 2.55. The 13C NMR (Table 1) and HSQC spectra of 1 indicated the presence of 3 carbonyl groups, 5 quaternary, 7 methine, 5 methylene and 5 methyl carbons. The labdane diterpene skeleton was established based on HMBC correlations of Me-17 (δH 1.72, s, 3H) to C-7, C-8 and C-9 (δC 121.9, 134.7 and 54.0); Me-19 (δH 1.30, s, 3H) to C-3, C-4 and C-5 (δC 77.7, 51.2 and 46.1); Me-20 (δH 0.82, s, 3H) to C-1, C-5 and C-9 (δC 36.2, 46.1 and 54.0) (Figure 2). A carboxylic acid group was assigned to the C-3 position based on the HMBC correlation between Me-19 and C-18 (δC 179.2). Further examination of the 1H NMR spectrum of 1 revealed characteristic signals of an angeloyl group. An olefinic proton (δH 6.03, qq, J = 7.0, 1.5 Hz, 1H), two methyl groups (δH 1.93, dq, J = 7.0, 1.5 Hz, 3H and 1.83, m, 3H), and the corresponding carbons (δC 167.3, 128.1, 138.3, 15.9 and 20.7) were assigned unambiguously to C-1' – C-5' based on HSQC and HMBC correlations. The HMBC spectrum also established correlations between the C-12 methylene protons (δH 2.55, m and 2.30, m, each 1H) to C-13, C-14 and C-16 (δC 138.4, 143.6 and 171.3), and from the oxygenated H-15 (δH 6.12, s, 1H) to C-13 and H-14 (δH 6.88, s, 1H), to C-15 (δC 96.7). These correlations suggested the presence of a hydroxy-furanone moiety, as shown in Figure 1. The relative configuration of compound 1 was confirmed by NOESY correlations between 3-H to 5-H, Me-19 to Me-20, and Me-20 to 11-H; the configuration at C-15 was not assigned (Figure 2). The spectroscopic data showed satisfactory agreement with those recorded for related labdane derivatives by Bohlmann et al. [7b].

Table 1.

1H and 13C NMR Data (δ, ppm) for compounds 1 in CDCl3

1 2
Posn δHb δCc δHb δCc
1 1.97 m, 1.36 m 36.7, CH2 1.93m, 1.31m 36.7, CH2
2 1.93 m, 1.68 m 25.1, CH2 2.05 m, 1.65 m 25.2, CH2
3 5,23 dd (11.9, 4.0) 77.7, CH 5.27 dd (12.0,
3.7)
77.7, CH
4 - 51.2, C - 51.1, C
5 2.05 m 46.1, CH 2.02 m 46.1, CH
6 1.95 m, 2.07 m 23.6, CH2 1.84 m, 1.68 m 23.8, CH2
7 5.36 brs 121.9, CH 5.35 brs 122.1, CH
8 - 134.7, C - 134.6, C
9 1.79 m 54.0, CH 1.75 m 54.2, CH
10 - 36.2, C - 36.2, C
11 1.74 m, 1.49 m 25.0, CH2 1.69 m, 1.48 m 25.0, CH2
12 2.55 m, 2.30 m 27.4, CH2 2.54 m, 2.27 m 27.5, CH2
13 - 138.4, C - 138.7/ 138.8, C
14 6.88 s 143.6, CH 6.80 s 142.1/ 142.2, CH
15 6.12 s 96.7, CH 5.75 d (1.3) 102.6/ 102.7, CH
16 - 171.3, C - 171.4, C
17 1.72 s 22.1, CH3 1.71 s 22.1, CH3
18 - 179.2, C - 180.2, C
19 1.30 s 12.0, CH3 1.27 s 12.1, CH3
20 0.82 s 14.1, CH3 0.81 s 14.0, CH3
1' - 167.3, C - 167.5, C
2' - 128.1, C - 128.1, C
3' 6.03 qq (7.0, 1.5) 138.3, CH 6.02 qq (7.0, 1.5) 138.3, CH
4' 1.93 dq (7.0, 1.5) 15.9, CH3 1.93, brd (7.5) 15.9, CH3
5' 1.83 m 20.7, CH3 1.82 brs 20.8, CH3
OMe 3.59 s 57.35/57.32, CH3
a

Assignments based on analysis of 2D NMR spectra.

b

Data (δ) measured at 500 MHz; s =singlet, br s =broad singlet, d =doublet, dd =doublet of doublets, dq =doublet of quartets, qq =quartet of quartets, m =multiplet. J values are in Hz and are omitted if the signals overlapped as multiplets. The overlapped signals were assigned from HSQC and HMBC spectra without designating multiplicity.

c

Data (δ) measured at 125 MHz; CH3, CH2, CH, and C multiplicities were determined by an HSQC experiment.

Figure 2.

Figure 2

HMBC (left) and NOESY (right) correlations of compound 1.

Figure 1.

Figure 1

Structures of compounds 1–2 isolated from G. sarothrae

Compound 2 was obtained as a colorless oil and had the molecular formula C26H36O7 as indicated by HRESIMS analysis (m/z 461.2560 [M+H]+, calcd. for C26H37O7+, 461.2534; 483.2361 [M+Na]+, calcd. for C26H36NaO7+, 483.2354). Examination of its 1H-NMR spectroscopic data indicated that compound 2 was similar to compound 1, except for the presence of a methoxy group in place of a hydroxy group. Placement of the methoxy group was determined by an HMBC correlation between the methoxy protons and C-15. Examination of the NOESY correlations of compound 2 suggested that its relative configuration was identical to that of compound 1. Compound 2 was obtained as a mixture of C-15 epimers that were not separable by HPLC, resulting in two sets of signals for C-13, C-14, C-15 and –OMe [10]. Compound 2 might possibly be an artefact formed by reaction of 1 with MeOH during the extraction of the plant material. However, we were unable to collect fresh plant material and extract it with a different solvent to confirm this hypothesis.

Compounds 1 and 2 were evaluated for their antimalarial activity against the chloroquine/mefloquine-resistant Dd2 strain of P. falciparum. Compound 1 exhibited moderate antiplasmodial activity with an IC50 value of 10.4 ± 4.3 µM in this assay, while compound 2 was inactive at doses below 20 µg/mL. The activity of compound 1 is thus most likely associated with its ring-opened α,β-unsaturated aldehyde form, since 2 is incapable of ring opening under mild conditions.

Experimental section

General experimental procedures

Optical rotations were recorded on a JASCO P-2000 polarimeter. UV spectra were measured on a Shimadzu UV-1201 spectrophotometer. IR spectra were measured on a MIDAC M-series FTIR spectrometer. NMR spectra were recorded in CDCl3 on a Bruker Avance 500 spectrometer. Chemical shifts are given in δ (ppm), and coupling constants are reported in Hz. Mass spectra were obtained on an Agilent 6220 LC-TOF-MS in the positive ion mode. Open column chromatographies were performed using Sephadex LH-20 (I.D.×L 3×50 cm) and Si-diol (I.D.×L 2.5 ×35 cm, 40–63 µm). HPLC separation was performed on a Shimadzu LC-10AT instrument with a semipreparative C18 Phenomenex Luna column (5 µm, 250 × 10 mm).

Antimalarial bioassay

The effect of each fraction and pure compound on in vitro parasite growth of Dd2 strain was measured in a 72 h growth assay in the presence of inhibitor as described previously with minor modifications [11a,11b]. Ring stage parasite cultures (100 µL per well, with 1% hematocrit and 1% parasitaemia) were grown for 72 h in the presence of increasing concentrations of the inhibitor in a 5.05% CO2, 4.93% O2 and 90.2% N2 gas mixture at 37 °C. After 72 h in culture, parasite viability was determined by DNA quantitation using SYBR Green I as described previously [11b]. The half-maximum inhibitory concentration (IC50) values were calculated with KaleidaGraph software using a nonlinear regression curve fitting. IC50 values are the average of three independent determinations with each determination in duplicate, and are expressed ± S.E.M. Artemisinin was used as the positive control with an IC50 of 6 ± 1 nM.

Plant material

Leaves and stems of G. sarothrae Kuntze were collected on the edge of a lake near Saskatoon, Canada (52.10N, 106.40W) by Cori M. Morenberg under the auspices of the New York Botanical Garden. A voucher specimen is on deposit under accession number CM00068a.

Extraction and isolation

Dried, powdered plant material was exhaustively extracted with MeOH to give a MeOH-soluble extract designated X-5689; a total of 800 mg of this extract was made available to Virginia Tech. This extract (IC50 between 5 and 10 µg/mL aganist P. falciparum Dd2 strain) was suspended in aqueous MeOH (MeOH:H2O, 9:1, 100 mL) and extracted with hexane (5×100 mL portions). Evaporation of the solvent afforded 155.2 mg of hexane soluble materials. The aqueous fraction was then diluted to MeOH-H2O, 6:4 (150 mL) and further extracted with CH2Cl2 (5×100 mL portions) to yield 212.3 mg of CH2Cl2 fraction and 429.9 mg of aqueous fraction. The active hexane and CH2Cl2 fractions (IC50 around 5 µg/mL) were combined and subjected to size exclusion open column chromatography (I.D.×L 3×50 cm) on Sephadex LH-20 eluted with CH2Cl2:MeOH, 1:1. Four fractions (F1: 155.7 mg, F2: 52.9 mg, F3: 111.0 mg, F4: 43.3 mg) were collected based on TLC profile. The most active fraction F3 (IC50 between 2.5~5 µg/mL) was then subjected to Si-diol open column chromatography (I.D.×L 2.5 ×35 cm, 40–63 µm) eluted with EtOAc:hexane (1:4) to give five subfractions indexed F3-1 (16.6 mg), F3-2 (23.5 mg), F3-3 (19.7 mg), F3–4 (16.8 mg) and F3-5 (28.6 mg). Fractions F3-3 (IC50 around 2.5 µg/mL) and F3–4 (IC50 between 2.5~5 µg/mL) were combined and further separated by HPLC on a semipreparative C18 column (Phenomenex Luna column, 5 µm, 250 × 10 mm) eluted with a solvent gradient from CH3CN:H2O, 50:50 to 60:40 from 0 to 10 min, to 100:0 from 10 to 30 min, ending with 100% CH3CN from 30 to 40 min at a flow rate of 2.5 mL/min. This process gave compounds 1 (2.3 mg, tR 12.5 min) and 2 (1.2 mg, tR 22.0 min).

3α-angeloyloxy-15-hydroxylabda-7,13-dien-16,15-olid-18-oic acid (1)

Colorless oil, [α]D23: +21.7 (c 0.037, MeOH);

UV (MeOH) λmax (log ε) 221 (4.83);

IR (film) νmax 3332, 1657, 1451, 1024 cm−1;

1H NMR (500 MHz, CDCl3): Table 1.

13C NMR (125 MHz, CDCl3): Table 1.

HRESIMS (pos.): m/z [M+Na]+, calcd. for C25H34O7Na+: 469.2197, found: 469.2218; [2M+Na]+, calcd. for C50H68O14Na+, 915.4501, found: 915.4543.

3α-angeloyloxy-15-methoxylabda-7,13-dien-16,15-olid-18-oic acid (2)

Colorless oil. [α]D23: +16.5(c 0.030, MeOH);

UV (MeOH) λmax (log ε) 218 (4.89);

IR (film) νmax 3324, 1641, 1452, 1017 cm−1;

1H NMR (500 MHz, CDCl3): Table 1.

13C NMR (125 MHz, CDCl3): Table 1.

HRESIMS (pos.): m/z [M+H]+, calcd. for C26H37O7+, 461.2534, found: 461.2560; [M+Na]+, calcd. for C26H36NaO7+, 483.2354, found: 483.2361.

Supplementary Material

SI

Acknowledgments

This project was supported by the National Center for Complementary and Integrative Health under award 1 R01 AT008088-01, and this support is gratefully acknowledged. This work was also supported by the National Science Foundation under Grant No. CHE-0619382 for purchase of the Bruker Avance 500 NMR spectrometer and Grant No. CHE-0722638 for the purchase of the Agilent 6220 mass spectrometer. We thank Mr. B. Bebout for obtaining the mass spectra. We gratefully acknowledge Cori M. Morenberg of the New York Botanical Garden for the provision of plant material.

Footnotes

Supplementary data: 1H and 13C NMR spectra of compounds 1 and 2 are available in electronic form on the publisher’s website.

References

  • 1.Everitt JH, Pettit RD, Alaniz MA. Remote sensing of broom snakeweed (Gutierrezia sarothrae) and spiny aster (Aster spinosus) Weed Science. 1987:295–302. [Google Scholar]
  • 2.Lucero ME, Fredrickson EL, Estell RE, Morrison AA, Richman DB. Volatile composition of Gutierrezia sarothrae (broom snakeweed) as determined by steam distillation and solid phase microextraction. Journal of Essential Oil Research. 2006;18:121–125. [Google Scholar]
  • 3.Elmore FH. The University of New Mexico Bulletin, Monograph Series. 7. Vol. 1. Albuquerque, New Mexico: University of New Mexico School of American Research; 1944. Ethnobotany of the Navajo. [Google Scholar]
  • 4.Swank GR. Albuquerque, New Mexico: University of New Mexico; 1932. The Ethnobotany of the Acoma and Laguna Indians. M.S. Thesis. [Google Scholar]
  • 5.Epstein WW, Seidel JL. Monoterpenes of Gutierrezia sarothrae. Journal of Agricultural and Food Chemistry. 1989;37:651–654. [Google Scholar]
  • 6.Hradetzky D, Wollenweber E, Roitman JN. Flavonoids from the leaf resin of snakeweed, Gutierrezia sarothrae. Zeitschrift für Naturforschung C. 1987;42:73–76. [Google Scholar]
  • 7.a) Bohlmann F, Zdero C, King RM, Robinson H. Neue labdan-derivate aus Gutierrezia-arten. Phytochemistry. 1979;18:1533–1537. [Google Scholar]; b) Bohlmann F, Zdero C, King RM, Robinson H. Gutierrezial and further diterpenes from Gutierrezia sarothrae. Phytochemistry. 1984;23:2007–2012. [Google Scholar]
  • 8.Ulubelen A, Caldwell ME, Cole JR. Isolation of an antitumor proteinaceous substance from Gutierrezia sarothrae (Compositae) Journal of Pharmaceutical Sciences. 1965;54:1214–1216. doi: 10.1002/jps.2600540830. [DOI] [PubMed] [Google Scholar]
  • 9.a) Liu Y, Rakotondraibe LH, Brodie PJ, Wiley JD, Cassera MB, Miller JS, Ratovoson F, Rakotobe E, Rasamison VE, Kingston DGI. Antimalarial 5,6-dihydro-α-pyrones from Cryptocarya rigidifolia: Related bicyclic tetrahydro-α-pyrones are artifacts. Journal of Natural Products. 2015;78:1330–1338. doi: 10.1021/acs.jnatprod.5b00187. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Harinantenaina L, Bowman JD, Brodie PJ, Slebodnick C, Callmander MW, Rakotobe E, Randrianaivo R, Rasamison VE, Gorka A, Roepe PD, Cassera MB, Kingston DGI. Antiproliferative and antiplasmodial dimeric phloroglucinols from Mallotus oppositifolius from the Madagascar dry forest. Journal of Natural Products. 2013;76:388–393. doi: 10.1021/np300750q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Starks CM, Williams RB, Goering MG, O’Neil-Johnson M, Norman VL, Hu J-F, Garo E, Hough GW, Rice SM, Eldridge GR. Antibacterial clerodane diterpenes from Goldenrod (Solidago virgaurea) Phytochemistry. 2010;71:104–109. doi: 10.1016/j.phytochem.2009.09.032. [DOI] [PubMed] [Google Scholar]
  • 11.a) Bennett TN, Paguio M, Gligorijevic B, Seudieu C, Kosar AD, Davidson E, Roepe PD. Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Antimicrobial Agents and Chemotherapy. 2004;48:1807–1810. doi: 10.1128/AAC.48.5.1807-1810.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrobial Agents and Chemotherapy. 2004;48:1803–1806. doi: 10.1128/AAC.48.5.1803-1806.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SI

RESOURCES